12 Penny Stocks with Insider Buying in 2026

8. Wellgistics Health, Inc. (NASDAQ:WGRX)

Share Price as of Last Close of March 27: $0.10

Insider Ownership: 56.05%

Wellgistics Health, Inc. (NASDAQ:WGRX) is one of the stocks with Insider buying in 2026.

TheFly reported on March 23 that WGRX announced it had signed a non-binding, non-exclusive Letter of Intent to explore a potential all-stock acquisition of Neuritek Therapeutics, a company specializing in neuroscience research. The proposed $105 million deal, if completed, aims to expand WGRX’ existing healthcare platform by integrating research capabilities alongside its technology-driven pharmacy distribution and services operations.

By combining prescription fulfillment, wholesale distribution, and AI-enabled patient access, Wellgistics Health, Inc. (NASDAQ:WGRX) seeks to better connect manufacturers, providers, and independent pharmacies nationwide. The acquisition could improve coordination between drug development and commercialization, enhance pipeline visibility, support new revenue opportunities, and create a more integrated platform to strengthen long-term shareholder value.

In a recent corporate move, on March 19, WGRX converted roughly $2 million of accrued compensation into common stock at $0.20 per share, resulting in the issuance of about 10 million shares.

Alongside this, the company granted 10 million warrants exercisable at $0.01 per share with a five-year term. The conversion, approved by independent board members, reflects management’s confidence in the company’s strategy and aligns leadership incentives with long-term shareholder value. Newly issued shares are subject to a six-month lock-up, with customary exceptions. This transaction is designed to reinforce commitment to the company’s growth while supporting alignment between executives, directors, and shareholders.

Wellgistics Health, Inc. (NASDAQ:WGRX) is a Tampa‑based healthcare and pharmaceutical logistics company offering wholesale distribution, prescription fulfillment, technology‑enabled pharmacy services, and clinical support to independent pharmacies and manufacturers.